CLICK HERE TO JOIN THE CASE

If you are an investor in Edwards Lifesciences and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than December 13, 2024, to serve as a lead plaintiff for the purported class.  If you have losses, we encourage you to contact us to learn more about the lead plaintiff process.

Edwards Lifesciences is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement, including Transcatheter Aortic Valve Replacement (“TAVR”).

According to the complaint, on July 24, 2024, after markets closed, Edwards Lifesciences released below-expectation financial results for the second quarter of 2024 and slashed its sales growth guidance for the TAVR platform for fiscal 2024 to 5 to 7% from its prior guidance of 8 to 10%.  The Company attributed the TAVR setback to the “continued growth and expansion of structural heart therapies … [which] put pressure on hospital workflows.”

On this news, the price of Edwards Lifesciences stock fell $27.25 per share, over 31%, to close at $59.70 per share on July 25, 2024.

The complaint alleges, among other things, that throughout the Class Period TAVR’s growth was at risk and that Defendants made false and/or materially misleading statements that overstated hospital desire to continue to utilize the Company’s TAVR procedures over newer, innovative structural heart therapies.

WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

If you have any questions about this Notice, your rights, or your interests, please contact:

CONTACT:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
pmayer@kaplanfox.com

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
lking@kaplanfox.com